Yun Huang

110 Xiangya Road
Changsha, 410078, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Turicibacter sanguinis is a candidate gut microbial pathobiont that promotes metabolic dysfunction-associated steatohepatitis.

Turicibacter sanguinis is a candidate gut microbial pathobiont that promotes metabolic dysfunction-associated steatohepatitis.

Journal: mSystems

Published: May 18, 2026

Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data.

Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data.

Journal: American journal of hypertension

Published: July 14, 2025

Gut bacteria and the host synergies promote resveratrol metabolism and induce tolerance in ALD mice.

Gut bacteria and the host synergies promote resveratrol metabolism and induce tolerance in ALD mice.

Journal: NPJ biofilms and microbiomes

Published: November 15, 2024

Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China.

Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China.

Journal: Journal of cardiovascular pharmacology

Published: June 13, 2023

5-Lipoxygenase Contributes to Benzo[a]pyrene-Induced Cytotoxicity and DNA Damage in Human Bronchial Epithelial Cells.

5-Lipoxygenase Contributes to Benzo[a]pyrene-Induced Cytotoxicity and DNA Damage in Human Bronchial Epithelial Cells.

Journal: International journal of toxicology

Published: December 20, 2022

Resveratrol in Liquor Exacerbates Alcoholic Liver Injury with a Reduced Therapeutic Effect in Mice: An Unsupervised Herbal Wine Habit Is Risky.

Resveratrol in Liquor Exacerbates Alcoholic Liver Injury with a Reduced Therapeutic Effect in Mice: An Unsupervised Herbal Wine Habit Is Risky.

Journal: Nutrients

Published: September 30, 2022

A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus.

A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus.

Journal: Cancers

Published: June 09, 2022

ARTCDP: An automated data platform for monitoring emerging patterns concerning road traffic crashes in China.

ARTCDP: An automated data platform for monitoring emerging patterns concerning road traffic crashes in China.

Journal: Accident; analysis and prevention

Published: January 26, 2022

Hepatic stellate cell-released CXCL1 aggravates HCC malignant behaviors through the MIR4435-2HG/miR-506-3p/TGFB1 axis.

Hepatic stellate cell-released CXCL1 aggravates HCC malignant behaviors through the MIR4435-2HG/miR-506-3p/TGFB1 axis.

Journal: Cancer science

Published: December 20, 2021

Comprehensive Analyses of the Infiltrating Immune Cell Landscape and Its Clinical Significance in Hepatocellular Carcinoma.

Comprehensive Analyses of the Infiltrating Immune Cell Landscape and Its Clinical Significance in Hepatocellular Carcinoma.

Journal: International journal of general medicine

Published: June 30, 2021

The systemic immune-inflammation index-based model is an effective biomarker on predicting central lymph node metastasis in clinically nodal-negative papillary thyroid carcinoma.

The systemic immune-inflammation index-based model is an effective biomarker on predicting central lymph node metastasis in clinically nodal-negative papillary thyroid carcinoma.

Journal: Gland surgery

Published: May 10, 2021

A Bibliometric Analysis of 8,276 Publications During the Past 25 Years on Cholangiocarcinoma by Machine Learning.

A Bibliometric Analysis of 8,276 Publications During the Past 25 Years on Cholangiocarcinoma by Machine Learning.

Journal: Frontiers in oncology

Published: March 30, 2021

Showing 1-12 of 44

Last Updated: 09/26/2026